High-dose fasudil preserves postconditioning against myocardial infarction under hyperglycemia in rats: role of mitochondrial KATP channels.

High-dose fasudil preserves postconditioning against myocardial infarction under hyperglycemia in rats: role of mitochondrial KATP channels.
复制标题

DOI:
10.1186/1475-2840-11-28
复制
发表时间:
2012-03-22
影响因子:
9.3
通讯作者:
Sumikawa K
Sumikawa K
中科院分区:
医学1区
文献类型:
--
作者:
Ichinomiya T;Cho S;Higashijima U;Matsumoto S;Maekawa T;Sumikawa K

文献摘要

参考文献

被引文献

相似文献

目前的研究旨在确定Rho激酶抑制剂盐酸法舒地尔(fasudil)在高血糖和正常血糖下是否具有心肌后处理(PostC)活性,如果有的话,该作用是否可以通过线粒体ATP敏感钾(m-KATP)通道介导。雄性斯普拉格-道利大鼠用戊巴比妥钠麻醉。打开胸腔后,所有大鼠均接受 30 分钟冠状动脉闭塞,然后再灌注 2 小时。大鼠在正常血糖或高血糖条件下再灌注前接受低剂量(0.15 mg/kg)或高剂量(0.5 mg/kg)法舒地尔或二氮嗪(一种 m-KATP 通道开放剂)10 mg/kg。在另一组中,大鼠在接受高剂量法舒地尔之前接受 5-羟基癸酸 (5HD)(一种 m-KATP 通道阻滞剂),剂量为 10 毫克/公斤。心肌梗塞面积以危险面积 (AAR) 的百分比表示。在正常血糖下,与对照组(42±7%)相比,低剂量和高剂量法舒地尔和二氮嗪可减少心肌梗塞面积(分别为 AAR 的 23±8%、21±9% 和 21±10%)。在高血糖下,低剂量法舒地尔(40±11%)和二氮嗪(44±14%)不能发挥这种有益作用,但高剂量法舒地尔以与正常血糖(21±13%)下相同的方式减少心肌梗塞面积。 5HD 阻止法舒地尔诱导的心肌梗塞面积减少 (42 ± 13%)。 Fasudil 通过激活大鼠体内的 m-KATP 通道诱导 PostC 对抗心肌梗塞。尽管高血糖会减弱 PostC,但大剂量法舒地尔可以恢复心脏保护作用。
The current study was carried out to determine whether fasudil hydrochloride (fasudil), a Rho-kinase inhibitor, has myocardial postconditioning (PostC) activity under hyperglycemia as well as normoglycemia, and if so, whether the effects could be mediated by mitochondrial ATP-sensitive potassium (m-KATP) channels. Male Sprague-Dawley rats were anesthetized with sodium pentobarbital. After opening the chest, all rats underwent 30-min coronary artery occlusion followed by 2-h reperfusion. The rats received low-dose (0.15 mg/kg) or high-dose (0.5 mg/kg) fasudil or diazoxide, an m-KATP channel opener, at 10 mg/kg, just before reperfusion under normoglycemic or hyperglycemic conditions. In another group, rats received 5-hydroxydecanoic acid (5HD), an m-KATP channel blocker, at 10 mg/kg, before high-dose fasudil. Myocardial infarct size was expressed as a percentage of area at risk (AAR). Under normoglycemia, low-dose and high-dose fasudil and diazoxide reduced myocardial infarct size (23 ± 8%, 21 ± 9% and 21 ± 10% of AAR, respectively) compared with that in the control (42 ± 7%). Under hyperglycemia, low-dose fasudil (40 ± 11%) and diazoxide (44 ± 14%) could not exert this beneficial effect, but high-dose fasudil reduced myocardial infarct size in the same manner as under normoglycemia (21 ± 13%). 5HD prevented fasudil-induced reduction of myocardial infarct size (42 ± 13%). Fasudil induces PostC against myocardial infarction via activation of m-KATP channels in the rat. Although hyperglycemia attenuates the PostC, high-dose fasudil can restore cardioprotection.
DOI: 10.1186/1475-2840-11-8
发表时间: 2012-01-18
影响因子: 9.3
作者:
Chen ZC;Cheng YZ;Chen LJ;Cheng KC;Li Y;Cheng J
通讯作者: Cheng J
DOI: 10.2143/ac.65.4.2053900
发表时间: 2010-08-01
期刊: ACTA CARDIOLOGICA
影响因子: 1.6
作者:
Ergelen, Mehmet;Uyarel, Huseyin;Ilhan, Erkan
通讯作者: Ilhan, Erkan
DOI: 10.1097/00000542-200306000-00013
发表时间: 2003-06-01
期刊: ANESTHESIOLOGY
影响因子: 8.8
作者:
Kehl, F;Krolikowski, JG;Kersten, JR
通讯作者: Kersten, JR
DOI: 10.2119/molmed.2009.00121
发表时间: 2010-07-01
期刊: MOLECULAR MEDICINE
影响因子: 5.7
作者:
Juan-Zhang;Bian, Hong-Jun;Ji, Xiao-Ping
通讯作者: Ji, Xiao-Ping
DOI: 10.1097/fjc.0b013e31802ef532
发表时间: 2007-03-01
影响因子: 3
作者:
Fukumoto, Yoshihiro;Mohri, Masahiro;Shimokawa, Hiroaki
通讯作者: Shimokawa, Hiroaki